Fig. 1.

Schematic Workflow describing screening and enrollment procedure, MoMP collection, and treatment selection. After patients were enrolled in the study, a biopsy of the metastatic lesion was collected and sent for MoMP. Molecular data were discussed by the TSC and used to identify FDA‐approved agents targeting the identified targets.